{
  "tweet": {
    "edit_info": {
      "initial": {
        "editTweetIds": [
          "794218633077477377"
        ],
        "editableUntil": "2016-11-03T17:44:12.651Z",
        "editsRemaining": "5",
        "isEditEligible": true
      }
    },
    "retweeted": false,
    "source": "<a href=\"http://twitter.com/download/iphone\" rel=\"nofollow\">Twitter for iPhone</a>",
    "entities": {
      "hashtags": [],
      "symbols": [],
      "user_mentions": [
        {
          "name": "Ben Goldacre",
          "screen_name": "bengoldacre",
          "indices": [
            "3",
            "15"
          ],
          "id_str": "6705042",
          "id": "6705042"
        },
        {
          "name": "Sanofi",
          "screen_name": "sanofi",
          "indices": [
            "116",
            "123"
          ],
          "id_str": "35846368",
          "id": "35846368"
        }
      ],
      "urls": [
        {
          "url": "https://t.co/WUNCqutCzw",
          "expanded_url": "https://f1000research.com/articles/5-2629/v1",
          "display_url": "f1000research.com/articles/5-262…",
          "indices": [
            "32",
            "55"
          ]
        }
      ]
    },
    "display_text_range": [
      "0",
      "139"
    ],
    "favorite_count": "0",
    "id_str": "794218633077477377",
    "truncated": false,
    "retweet_count": "0",
    "id": "794218633077477377",
    "possibly_sensitive": false,
    "created_at": "Thu Nov 03 16:44:12 +0000 2016",
    "favorited": false,
    "full_text": "RT @bengoldacre: Read our paper https://t.co/WUNCqutCzw to see how we built this live tracker of withheld trials. \n\n@sanofi please publish…",
    "lang": "en"
  }
}